Research paperChagas' disease in Aboriginal and Creole communities from the Gran Chaco Region of Argentina: Seroprevalence and molecular parasitological characterization
Graphical abstract
Introduction
Chagas' disease represents a devastating health and social threat to around eight million infected people in 21 Latin American countries, and is emergent in non-endemic countries introduced by extensive global migrations and perpetuated by means of vertical transmission (Rodrigues Coura and Viñas, 2010). The infection mainly affects rural and neglected populations, such as Aboriginal groups, since they are highly exposed to the risk of vectorial transmission, as a consequence of poverty and lack of sanitized households. Many Creole populations resulting from miscegenation with European colonists and immigrants coexist within these native communities.
In Argentina, the Chagas' disease National Program has achieved important decreases in the rates of parasitic transmission by blood transfusion, vectorial pathway and prenatal care for congenital transmission, especially among non-indigenous communities. Deficient spraying and discontinuity of surveillance favors persistence of highly endemic areas (Zaidenberg et al., 2004). Aboriginal houses are much more likely to be infested with Triatoma infestans than Creoles' houses; indigenous people mostly tend to thatch the roofs and often sleep on the floor, providing the vector with a more primary habitat than just mud walls. Moreover, the lack of timely reporting of re-infestation opens the way for renewed transmission (Dell'Arciprete et al., 2014). Besides, among indigenous groups, culture and language differences make control efforts more difficult (Dell'Arciprete et al., 2014).
By year 2010, according to the Survey of Indigenous Population of the National Institute of Statistics and Census (Censo, 2010), there were 955,032 people in Argentina who self-recognized and/or identified themselves as belonging to an indigenous community minority. At the present time, ten well-defined indigenous ethnias are recognized in the country, 90% of them living within “the Gran Chaco Americano” region.
Three different indigenous ethnias inhabit the province of Chaco, namely Qom, spanish-called Toba, that includes 30,000 individuals living in urban and rural areas of central and southeastern plains of the province; Wichis, spanish-called Mataco, that comprises approximately 6500 individuals living in rural communities in the northwestern corner of the province called “Monte Impenetrable Chaqueño” and Moquoít, spanish-called Mocoví, that includes approximately 6500 individuals living in the southwestern area of the province. Moreover, in the province of Formosa, the Pilagá, originally named Pit'laxá, are nowadays situated in 19 settlements. Indigenous populations mostly live in rural locations with severe housing constrictions and with limited access to health care services. In many locations there are no medical facilities within or close to the settlements and there is also lack of medical staff trained to understand their cultural characteristics and languages (Petherick, 2010).
Currently, Trypanosoma cruzi is partitioned into six discrete typing units (DTUs) renamed by consensus as TcI–TcVI (Zingales et al., 2009, Zingales et al., 2012). Epidemiologically relevant T. cruzi DTUs and genetic parasite diversity infecting native populations remain to be determined. Most DTU typing methods have used DNA from cultured parasites, which may underestimate the diversity of natural populations due to subpopulation selection during culturing procedures (Diosque et al., 2003, Macedo et al., 2004). Moreover, parasite cultures from blood samples of chronically infected cases have very low sensitivity. In the last years, sensitive PCR strategies have been developed for typing of T. cruzi in clinical samples (Burgos et al., 2007, Burgos et al., 2010, Zingales et al., 2012, Monje-Rumi et al., 2015, Cura et al., 2015). This has opened the possibility to deepening our understanding of parasite genetic diversity in native communities.
In this context, this work aimed to characterize serological and parasitological features of affected Aboriginal and Creole communities residing in rural neglected areas of the Argentinean Gran Chaco.
Section snippets
Subjects and samples
Between August 2010 and March 2014, T. cruzi infection was searched in a total of 861 individuals inhabiting the Provinces of Chaco and Formosa, in the Argentinean Gran Chaco Region. A total of 604 out of 861 individuals belonged to eight Aboriginal communities at a) Province of Chaco: seven rural villages of Colonia Aborigen, N = 35 and Las Hacheras, N = 60 (ethnia Qom); Miraflores, N = 46 (ethnias Wichi and Qom); Misión Nueva Pompeya survey 2010, N = 55 Misión Nueva Pompeya survey 2014, N = 110 (ethnia
Seroprevalence in Aboriginal and Creole populations
Eight aboriginal communities were studied; seven reside in rural villages at the Provinces of Chaco and Formosa (496 individuals, Wichi, Pit'laxá, Mocoit and Qom) and one in the urban Mapic settlement of the suburbs of Resistencia city, known as “Gran Resistencia” (108 individuals, Qom) (Fig. 1 and Table 1). Furthermore, four rural villages inhabited by Creole populations were included (257 individuals).
Detection of seropositivity for T. cruzi allowed diagnosis of Chagas disease in 238 out of
Discussion
Despite significant gains in the reduction of Chagas disease burden in many endemic countries, active transmission remains in areas such as the Gran Chaco. High initial vector density, poor housing material, peridomestic infestation, insecticide resistance, and a lack of systematic insecticide spraying and vector surveillance have previously been incriminated for failure to interrupt and sustain interruption of transmission.
We have studied Aboriginal communities that inhabit highly endemic
Acknowledgments
We are grateful to Dr. Hector Freilij (Ministery of Health, Argentina) for the support in patients' management and to Dr. Sergio Sosa Estani (Instituto Nacional de Parasitología, Mario Fatala Chabén, Argentina) for providing material for serological analyses. We also thank to Dr.Susana Raselli, director of the Central Laboratory of Public Health in the Province of Chaco for facilitating the use of the Real Time PCR cycler. We thank M.Sc María de los Angeles Curto for parasite culturing and
References (44)
- et al.
Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina
Int. J. Parasitol.
(2008) - et al.
Multilocus enzyme electrophoresis analysis of Trypanosoma cruzi isolates from a geographically restricted endemic area for Chagas' disease in Argentina
Int. J. Parasitol.
(2003) - et al.
Trypanosoma cruzi diversity in the Gran Chaco: mixed infections and differential host distribution of TcV and TcVI
Infect. Genet. Evol.
(2015) - et al.
Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial
Acta Trop.
(2013) - et al.
Predominance of hybrid discrete typing units of Trypanosoma cruzi in domestic Triatoma infestans from the Bolivian Gran Chaco region
Infect. Genet. Evol.
(2013) - et al.
Analytical validation of quantitative real-time PCR methods for quantification of Trypanosoma cruzi DNA in blood samples from Chagas disease patients
J. Mol. Diagn.
(2015) - et al.
The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications
Infect. Genet. Evol.
(2012) - et al.
New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: a pilot short-term follow-up study with adult patients
Antimicrob. Agents Chemother.
(2015) - et al.
Seroprevalencia de la enfermedad de Chagas en 17 parajes del Monte Impenetrable de la Provincia del Chaco
Medicina
(2003) - et al.
How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children
PLoS Negl. Trop. Dis.
(2013)
Validation of laboratory-developed molecular assays for infectious diseases
Clin. Microbiol. Rev.
Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation
Clin. Infect. Dis.
Chagas disease in Ecuador: evidence for disease transmission in an indigenous population in the Amazon region
Mem. Inst. Oswaldo Cruz
Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina
Parasitology
Multiplex real-time PCR assay using TaqMan probes for the identification of Trypanosoma cruzi DTUs in Biological and clinical samples
PLoS Negl. Trop. Dis.
Genetic susceptibility to cardiac and digestive clinical forms of chronic Chagas disease: involvement of the CCR5 59029 A/G polymorphism
PLoS ONE
Cultural barriers to effective communication between indigenous communities and health care providers in Northern Argentina: an anthropological contribution to Chagas disease prevention and control
Int. J. Equity Health
Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients
PLoS Negl. Trop. Dis.
Analytical performance of a multiplex real-time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples
PLoS Negl. Trop. Dis.
Extracción de ADN de Trypanosoma cruzi mediante tratamiento con bromuro de hexadecil-trimetil-amonio
Biomedica
Cited by (25)
Development of vaccines for Chagas disease (CRUZIVAX): stakeholders’ preferences and potential impacts on healthcare
2023, Gaceta SanitariaCitation Excerpt :This study focuses on the Gran Chaco region, which spans in Argentina, Bolivia and Paraguay, and has a very high burden of Chagas disease. In many rural villages of this region, T. cruzi seroprevalence varies between 20% and 50% among children and adolescents under 15 years of age.7,8 Because of migration, Chagas disease has become a public health problem also in non-endemic areas.9–11
Potential association of Trypanosoma cruzi DTUs TcV and TcVI with the digestive form of Chagas disease
2020, Infection, Genetics and EvolutionCitation Excerpt :Conversely, the two TcV strains examined in the mentioned study shared 97.3% of its mHVR classes (Rusman et al., 2019). Taking into account that (i) TcI, TcII, TcV and TcVI are the DTUs described in human infections in Argentina (Cura et al., 2012; Lucero et al., 2016) (and also the DTUs identified in the present work); and (ii) TcI and TcII show a higher genetic diversity than TcV and TcVI; we consider that those samples that did not hybridize with the used probes probably correspond to infections due to TcI and/or TcII. Interestingly, samples that did not hybridize with any probe corresponded only to no-digestive patients (i.e. cardiac and asymptomatic forms of the disease).
Human infectiousness and parasite load in chronic patients seropositive for Trypanosoma cruzi in a rural area of the Argentine Chaco
2020, Infection, Genetics and EvolutionCitation Excerpt :The mean parasite load was 0.51 parasite equivalents per ml and its range was between 0 and 4.21. These values are similar to those reported in a neighboring rural area of Pampa del Indio (Sartor et al., 2017) and in chronic humans seropositive for T. cruzi (Alvarez et al., 2016; Bua et al., 2012; Duffy et al., 2013; Lucero et al., 2016; Melo et al., 2015; Ortiz et al., 2012). Similarly, 37% out of 100 chronic patients exhibited parasitemia ≤1 parasite equivalent per ml in Chile (Saavedra et al., 2016).
New human isolates of Trypanosoma cruzi confirm the predominance of hybrid lineages in domestic transmission cycle of the Argentinean Chaco
2018, Infection, Genetics and EvolutionCitation Excerpt :The latter procedure was implemented to increase the sensitivity of our analyses. Although T. cruzi DTUs have been successfully identified from whole blood, the probability of successful identification decreases markedly in chronic patients and with increasing age (Bontempi et al. 2016; Burgos et al. 2007; Cura et al. 2012; Lucero et al. 2016). All isolates here reported were from chronic patients, and 25% belonged to people aged ≥18 years.
Molecular diagnosis of Trypanosoma cruzi
2018, Acta Tropica